Australia due to become a major market for STENOCARE in 2024
STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO STENOCARE A/S (Stenocare) is experiencing stronger than expected sales (budgets vs. actual) performance in Australia and is now expanding its presence with a new medical cannabis oil product.Off to a good start: Stenocare, a leading Danish supplier of prescription-based medical cannabis oil products in Europe and Australia, entered the Australian market in the second half of 2022 with the initial Stenocare-branded Balanced 12.5-12.5 oil product. The response from both doctors and patients has exceeded the